Inventor

JUNE CARL H

US126 patents

⚠️ This page may combine multiple inventors who share the name “JUNE CARL H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JUNE CARL H

UNIV PENNSYLVANIA

Compositions and methods for treatment of cancer

Compositions and methods for treatment of cancer

Compositions and methods for treatment of cancer

Compositions and methods for treatment of cancer

Use of chimeric antigen receptor-modified T cells to treat cancer

Methods for treatment of cancer

Compositions for treatment of cancer

Compositions for treatment of cancer

Compositions for treatment of cancer

Methods for treatment of cancer

Compositions for treatment of cancer

Methods for treatment of cancer

Enhancing activity of CAR T cells by co-introducing a bispecific antibody

Compositions and methods for generating a persisting population of T cells useful for the treatment of cancer

Use of the CD2 signaling domain in second-generation chimeric antigen receptors

Artificial antigen presenting cells and uses therefor

Altering gene expression in modified T cells and uses thereof

Methods for assessing the suitability of transduced T cells for administration

Compositions and methods for targeting stromal cells for the treatment of cancer

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

Use of ICOS-based CARs to enhance antitumor activity and CAR persistence

Methods of making chimeric antigen receptor-expressing cells

Use of a trans-signaling approach in chimeric antigen receptors

Artificial antigen presenting cells and uses thereof

US NAVY

Methods for selectively stimulating proliferation of T cells

Methods for selectively stimulating proliferation of T cells

Methods of treating HIV infected subjects

Methods for selectively stimulating proliferation of T cells

Methods for selectively stimulating proliferation of T cells

Methods for transfecting T cells

Methods for transfecting T cells

Methods for modulating T cell responses by manipulating intracellular signal transduction

Methods for modulating T cell survival by modulating bcl-XL protein level

Murine hybridoma and antibody binding to CD28 receptor secreted by the hybridoma and method of using the antibody

NOVARTIS AG

Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor

Treatment of cancer using humanized anti-CD19 chimeric antigen receptor

Anti-BCMA chimeric antigen receptor

CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell

GENETICS INST LLC

Methods for treating HIV infected subjects

Methods for selectively enriching TH1 and TH2 cells

GENETICS INST

Methods for selectively stimulating proliferation of T cells

Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells

JUNE CARL H

Use of chimeric antigen receptor-modified T-cells to treat cancer

Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool

UNIV MICHIGAN

Methods for transfecting T cells

Methods of treating autoimmune disease via CTLA-4Ig

BROGDON JENNIFER

Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells

Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor

INST GENETICS LLC

Methods for selectively stimulating proliferation of T cells

RILEY JAMES L

Artificial antigen presenting cells and uses therefor